Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patent foramen ovale and stroke.

Steven C Horton1, T Jared Bunch

  • 1Department of Cardiology, Department of Internal Medicine, LDS Hospital and University of Utah School of Medicine, Salt Lake City, USA. SCHorton@msn.com

Mayo Clinic Proceedings
|January 8, 2004
PubMed
Summary

Patent foramen ovale (PFO) closure significantly reduces embolic events. Medical treatments like aspirin or warfarin show limited benefit for stroke recurrence in PFO patients, especially with atrial septal aneurysm.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Duplex ultrasound assessment after venous vascular closure of 16-17 F OD femoral venotomy: AMBULATE EXPAND ultrasound substudy.

Heart rhythm O2·2026
Same author

Centers of Excellence Optimal Management Pathways for Atrial Fibrillation Specialty Services (COMPASS) early rhythm control treatment care pathway: A quality improvement initiative.

Heart rhythm O2·2026
Same author

Sequential Electrocardiographic Progression of Alternating Bundle Branch Block Culminating in Complete Atrioventricular Block.

JACC. Case reports·2026
Same author

Patient Care Pathways and Outcomes Following Newly Diagnosed Atrial Fibrillation.

Journal of the American Heart Association·2026
Same author

Safety and Efficacy of the VASCADE MVP® XL Venous Vascular Closure System for Management of Femoral Venotomy Following Catheter-Based Interventions Utilizing 16-17F OD Sheaths: The AMBULATE EXPAND Trial.

Journal of cardiovascular electrophysiology·2026
Same author

Hemodynamic Consequences and Clinical Outcomes With Intravenous Lidocaine Infusion in Patients With Atrial Fibrillation.

Journal of cardiovascular electrophysiology·2026

Area of Science:

  • Cardiology
  • Neurology
  • Embryology

Background:

  • Patent foramen ovale (PFO) is a common congenital heart defect with significant clinical implications.
  • PFO is linked to stroke, paradoxical embolism, and other serious conditions.
  • Mechanisms for stroke in PFO patients include paradoxical embolization and associated arrhythmias.

Purpose of the Study:

  • To review the clinical significance of PFO.
  • To evaluate treatment strategies for stroke prevention in PFO patients.
  • To assess the efficacy of PFO closure versus medical management.

Main Methods:

  • Review of prospective trials and existing literature on PFO.
  • Analysis of treatment outcomes for aspirin, warfarin, and PFO closure (surgical and catheter-based).
  • Assessment of successful closure criteria using transesophageal echocardiography.

Main Results:

  • Aspirin treatment did not prevent recurrent stroke in PFO patients with atrial septal aneurysm.
  • Warfarin did not offer additional benefit over antiplatelet therapy for stroke recurrence.
  • Both surgical and catheter-based PFO closure substantially decreased subsequent embolic events.

Conclusions:

  • PFO closure is effective in reducing embolic events.
  • Medical management alone is less effective for stroke prevention in specific PFO populations.
  • Further randomized trials are needed to compare anticoagulation with closure methods.

Related Experiment Videos